A novel therapy for pediatric juvenile spinal muscular atrophy

Zusatztext

There is no satisfactory therapy for many of the disabling genetic disorders such as pediatric juvenile spinal muscular atrophy (Wohlfart Kugelberg Welander syndrome). The aim of this book is to describe a novel therapy for pediatric juvenile spinal muscular atrophy which resulted in an obvious improvement that has never been reported before. Two unrelated Iraqi boys with pediatric juvenile spinal muscular atrophy were observed, and the one who was more severely affected was treated with a novel therapy which resulted in obvious improvement within less than one month. The less affected boy received no treatment and didnt show any improvement after few months.

Autorenportrait

Aamir Jalal Al Mosawi is advisor in pediatrics and pediatric psychiatry at the Children Teaching Hospital of Baghdad Medical City. He is the Head of Iraq Headquarter of Copernicus Scientists International Panel. He served as a member of the advisory council the International Association of Medical Colleges (IAMC).

Weitere Details